Advertisement

9 Assay for Serum Glycated Lipoproteins

  • Akira Tanaka
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 52)

Abstract

Modified low density lipoprotein (LDL) is considered to be a risk factor for the development and progression of atherosclerosis (1-3). Glycated LDL and oxidized LDL are the only modified lipoproteins that exist naturally in the human body, but oxidized LDL does not exist in the circulation because of the presence of many antioxidizing agents (4). LDL cannot be oxidized until it has entered the arterial wall from the circulation. The only modified LDL that exists in the circulation is glycated LDL. It has been shown to be more easily oxidized than native LDL (5-7). These findings indicate that the glycation of LDL may be the initial step in the development of atherosclerosis.

Keywords

Arterial Wall System Controller Analytical Temperature Column Oven Unbind Fraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lyons, T. J. (1991) Oxidized low density lipoproteins-A role in the pathogenesis of atherosclerosis in diabetes? Diabet. Med. 8, 411–419.CrossRefPubMedGoogle Scholar
  2. 2.
    Makita, T., Tanaka, A., Nakajima, K., Nakano, T., and Numano, N. (1999) Importance of glycation in acceleration of low density lipoprotein (LDL) uptake into macrophages in patients with diabetes mellitus. Int. Angiol. 18, 149–153.PubMedGoogle Scholar
  3. 3.
    Makita, T., Tanaka, A., and Numano, F.(1999) Effect of glycated low density lipoprotein on smooth muscle cell proliferation. Int. Angiol., in press.Google Scholar
  4. 4.
    Colaco, C. A. L. S. and Roser, B. J.(1994) Atherosclerosis and glycation. Bio As says 16, 145–147.Google Scholar
  5. 5.
    Lyon, T. J. (1992) Lipoprotein glycation and its metabolic consequences. Diabetes 41, 67–73.Google Scholar
  6. 6.
    Wolff, S. P. and Dean, R. T.(1987) Glucose autoxidation and protein modification;the potential role of autoxidative glycation in diabetes mellitus. Biochem. J. 245, 243–250.PubMedGoogle Scholar
  7. 7.
    Mullarkey, C. J., Edelstein, D., and Brownlee, M. (1990) Free radical generation by early glycation products; a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173, 932–939.CrossRefPubMedGoogle Scholar
  8. 8.
    Gonen, B., Baenziger, J., Schonfeld, G., Jacobson, D., and Farrar, P. (1981) Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cellinteractive properties. Diabetes 30, 875–878.CrossRefPubMedGoogle Scholar
  9. 9.
    Schleicher, E., Deufel, T., and Wieland, O. H. (1981) Non-enzymatic glycosylation of human serum lipoproteins. FEBS Lett. 129, 1–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Lopes-Virella, M. F. R., Klein, R. L., Lyons, T. J., Stevenson, H. C., and Witzum, J. L. (1988) Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37, 550–557.CrossRefPubMedGoogle Scholar
  11. 11.
    Gould, B. J., Hall, M., and Cook, J. G. H. (1984) A sensitive method for the measurement of glycosylated plasma proteins using affinity chromatography. Ann. Clin. Biochem. 21, 16–21.PubMedGoogle Scholar
  12. 12.
    Dhima, K., Ito, N., Abe, F., Hirota, M., Yano, M., Yamamoto, Y., Uchida, T., and Noguchi, K. (1988) High performance liquid chromatography assay of serum glycated albumin. Diabetology 31, 327–631.Google Scholar
  13. 13.
    Tanaka, A., Yui, K., Tomie, N., Baba, T., Tamura, M., Makita, T., Numano, F., Nakatani, S., and Kato, Y. (1997) New assay for glycated lipoproteins by highperformance liquid chromatography. Ann. N.Y. Acad. Sci. 811, 385–394.CrossRefPubMedGoogle Scholar
  14. 14.
    Okazaki, M., Sasamoto, K., Muramatsu, T., and Hosaki, S. (1997) Analysis of plasma lipoproteins by gel permeation chromatography, in Handbook of Lipoprotein Testing. (Rifai, N., ed.), AACC press, Washington, DC, pp. 531–548.Google Scholar
  15. 15.
    Numano, F., Tanaka, A., Makita, T., and Kishi, Y. (1997) Glycated lipoprotein and atherosclerosis. Ann. N.Y. Acad. Sci. 811, 100–114.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2001

Authors and Affiliations

  • Akira Tanaka
    • 1
  1. 1.Third Department of Internal MedicineTokyo Medical and Dental UniversityBunkyo-ku, Tokyo, Japan

Personalised recommendations